ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
Dow Jones
38.239,66
0,40%
Euro vs US Dollar
1,06965
-0,04%
Bitcoin
62.785,32
-1,50%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Madrigal Pharmaceuticals Inc (MDGL)

  7. Madrigal Pharmaceuticals Inc (MDGL) News

MDGL Madrigal Pharmaceuticals Inc

193,00
-1,38 (-0,71%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Madrigal Pharmaceuticals Inc MDGL NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
-1,38 -0,71% 193,00 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
192,49 189,00 195,58 193,33 194,38
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.4.202422:00GLOBEMadrigal Statement on the Passing of Dr. Stephen Harrison
23.4.202414:00GLOBEMadrigal Pharmaceuticals to Release First-Quarter 2024..
16.4.202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
09.4.202414:00GLOBEMadrigal Pharmaceuticals Announces U.S. Availability of..
03.4.202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
19.3.202404:58GLOBEMadrigal Pharmaceuticals Announces Pricing of Upsized $600..
18.3.202421:04GLOBEMadrigal Pharmaceuticals Announces Proposed Public Offering
15.3.202412:30IHMARKETNEWSAdobe Stock Drops Following Below-Estimate Projections,..
14.3.202421:15GLOBEMadrigal Pharmaceuticals Announces FDA Approval of..
06.3.202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
05.3.202414:00GLOBEMadrigal Pharmaceuticals Announces EMA Validation of its..
28.2.202413:10EDGAR2Form 8-K - Current report
28.2.202413:01EDGAR2Form 8-K - Current report
28.2.202413:01GLOBEMadrigal Pharmaceuticals Appoints Mardi C. Dier as Chief..
28.2.202413:00GLOBEMadrigal Pharmaceuticals Provides Corporate Updates and..
28.2.202412:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
21.2.202414:00GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
14.2.202420:50EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202415:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202423:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.2.202414:00GLOBEMadrigal Pharmaceuticals Announces Publication of the Phase..
06.2.202422:05GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
29.1.202414:00GLOBEMadrigal Pharmaceuticals Announces Additions to Its..
26.1.202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202423:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202423:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202421:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202421:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.1.202421:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.1.202414:00GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
18.1.202419:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202419:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202419:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202419:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.1.202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202419:45EDGAR2Form 8-K - Current report
04.1.202414:00GLOBEMadrigal Pharmaceuticals Presents Five Health Economics..
03.1.202422:30GLOBEMadrigal Pharmaceuticals to Present at the 42nd Annual J.P...
22.12.202322:30GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
18.12.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.12.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.12.202322:05EDGAR2Form SC 13D/A - General statement of acquisition of..
06.12.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.12.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.11.202322:30GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..
22.11.202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.11.202323:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
21.11.202323:24EDGAR2Form SC 13D/A - General statement of acquisition of..
21.11.202314:00GLOBEMadrigal Pharmaceuticals Appoints Ronald Filippo as Chief..
15.11.202322:45GLOBEMadrigal Pharmaceuticals Reports Inducement Grants under..

Kürzlich von Ihnen besucht

NASDAQ
MDGL
Madrigal Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten